BackHofseth BioCare ASA Overview
Hofseth BioCare ASA

Hofseth BioCare ASA Return on Equity

Hofseth BioCare ASA (HOFBF) has a ROE of 6824.48%, above the sector sector average of 11.3%.

Get informed when a big investor buys or sells

+ Follow

ROE

6824.48%

Return on Equity

6824.48%

Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.

ROE (Comparison Companies)

Loading

ROE History

Loading

ROE Comparison

Loading

Hofseth BioCare ASA (HOFBF) FAQ

Hofseth BioCare ASA posts a ROE of 6824.48%. That is above the sector sector average of 11.3%. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

For its sector stocks, a ROE near 11.3% is typical. Hofseth BioCare ASA's 6824.48% is higher that level. That is roughly 60314.0% above the sector mean. Whether that is a warning or an opportunity depends on growth outlook and other fundamentals shown elsewhere on Stockcircle.

Hofseth BioCare ASA's ROE moves when the underlying profit, equity, or asset base changes. Cost cuts, pricing power, buybacks, write-downs, and cyclical swings can all shift the percentage. The latest reading is 6824.48%; use YoY and peer views to separate noise from signal.

Context for HOFBF's ROE usually means three checks: (1) trend versus prior periods, (2) level versus peers (average 11.3%), and (3) consistency with growth and profitability. This page covers the first two; Hofseth BioCare ASA's other metric pages and overview cover the third.